ACTH(4–10) raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-12-30. Anything still debated is marked as such rather than presented as settled.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid from research suppliers |
| Solubility | Freely soluble in water | Also dissolves in aqueous buffers; solutions are used fresh |
| Typical storage temperature | -20 °C for lyophilized powder | Short-term transport at 2-8 °C is common |
| Common analytical method | Reverse-phase HPLC | Paired with mass spectrometry for identity confirmation |
| Common synonyms | ACTH(4-10) analogue; MEHFPGP | N-terminal methionine retained in the chain |
Routine characterization relies on reversed-phase high-performance liquid chromatography to establish purity and on mass spectrometry to confirm molecular identity. Electrospray ionization and matrix-assisted laser desorption ionization are both used for mass verification. Amino acid analysis and peptide mapping can detect sequence errors. Common impurities include truncated sequences, methionine sulfoxide formed by oxidation, and deamidated products. Chromatograms are usually recorded near 214 nm, where the peptide backbone absorbs, and purity is reported as the percentage area of the principal peak.
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Dichloroarcyriaflavin A synthase (EC 1.13.12.17) is an enzyme with systematic name dichlorochromopyrrolate,NADH:oxygen 2,5-oxidoreductase (dichloroarcyriaflavin A-forming). This enzyme catalyses the following overall chemical reaction:
Cannibalism among flocks is highly variable and when it is not problematic, then mortalities among production systems are similar. Opponents of beak trimming state that the practice reduces problem pecking by minor amounts compared to the trauma, injury, and harm done to the entire flock by beak trimming. Several countries have banned the practice, including Denmark (2013), Finland (1986), Germany (2017), the Netherlands (2019), Norway (1974) and Sweden (1988); analysts expect other European countries such as the UK to follow in the near future. Alternatives to beak trimming include enrichment or providing more space for the birds.
For example, in the figure showing trypanothione reductase from the human protozoan parasite Trypanosoma cruzi, two molecules of an inhibitor called quinacrine mustard are bound in its active site. The top molecule is bound reversibly, but the lower one is bound covalently as it has reacted with an amino acid residue through its nitrogen mustard group.
Sources: en.wikipedia.org
Hydrogen peroxide has a relatively elusive and highly unstable isomer called oxywater, also known as water oxide. Its chemical formula is H2OO and its systematic IUPAC name is oxidooxidanium. It is isoelectronic to fluoroamine and is a ylide. It rapidly decomposes to form hydrogen peroxide, the reaction mechanism for which is likely a 1,2-hydrogen shift.
In general relativity, a vanishing stress–energy tensor implies, through Einstein field equations, the vanishing of all the components of the Ricci tensor. Vacuum does not mean that the curvature of space-time is necessarily flat: the gravitational field can still produce curvature in a vacuum in the form of tidal forces and gravitational waves (technically, these phenomena are the components of the Weyl tensor). The black hole (with zero electric charge) is an elegant example of a region completely "filled" with vacuum, but still showing a strong curvature.
9 August – A second Police Service of Northern Ireland data breach is revealed after it emerges a spreadsheet containing the names of 200 officers was stolen from a car in July 2023. 10 August High street bargain homeware retailer Wilko goes into administration. The move puts 12,000 jobs across 400 shops at risk. Simon Byrne, the Chief Constable of the Police Service of Northern Ireland, says he is "deeply sorry" about two "industrial scale" data breaches, but will not resign over the controversy. Coronation of Charles III and Camilla: The Royal Mint unveils a special official Coronation 50 pence coin. 11 August Data from the Office for National Statistics shows the UK economy grew by an average 0.2% between April and June 2023. This includes a better than expected increase of 0.5% for June as a result of warm weather which boosted both the construction and hospitality industries. Migrants are temporarily moved from the Bibby Stockholm after traces of the Legionella bacteria are found in the water supply. The number of migrants who have crossed the English Channel since 2018 passes 100,000. 12 August England captain Harry Kane joins German champions Bayern Munich on a four-year deal, ending his record-breaking career at Tottenham Hotspur. Six people are killed and 58 rescued by British and French coastguards after a boat carrying migrants sinks off the French coast, near Sangatte, in the English Channel. 14 August – Health Secretary Steve Barclay confirms "no-one has been harmed" following the discovery of legionella bacteria on the Bibby Stockholm.
Parental care came about independently in: mammals, most birds, some insects, some fish and crocodilians. Regeneration, many different unrelated species can grow new limbs, tail or other body parts, if body parts are lost. The statocyst is a balance sensory receptor independently found in different organisms like: some aquatic invertebrates, including bivalves, cnidarians, echinoderms, cephalopods, and crustaceans. Also found in single-cell ciliate. A similar structure is also found in Xenoturbella. Hearing came about in many different unrelated species with the: tympanal organ, Johnston's organ and mammal/bird ears. Also the simpler hearing found in reptiles, with only the stapes bone. Pincushion-form starfish have evolved at least four times. Infrared vision is in many different unrelated species: pit viper snakes (rattlesnakes), pythons, vampire bats, and wood-boring wasps and fire beetles.
Sources: en.wikipedia.org
It consists mainly of animal experiments and small clinical reports, with much of the clinical material published in Russian-language journals. Large independent trials are scarce. Separating reliable effects from chance findings is consequently difficult.
A fraction of an intranasal dose is thought to reach the central nervous system, and this route is favoured partly for that reason. The proportion is not well characterized. Direct measurement in humans remains difficult with current methods.
Raised BDNF and NGF expression has been reported across several animal studies, which makes the signal fairly consistent. Whether the same change occurs in humans at usable doses is not established. It is best treated as a working hypothesis rather than a confirmed clinical mechanism.
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.